ArticleFrontiers in oncology2024

Targeting RNA N6-methyladenosine modification-- a novel therapeutic target for HER2- positive gastric cancer.

Lijun Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.